Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase NA 2Phase 3 1Phase 1/2 1

Status

Completed 23Unknown 5Terminated 3Withdrawn 1Recruiting 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 3CNS 2

Conditions

Recurrence 2Lymphoma 2Glioblastoma 2Hodgkin Disease 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Procarbazine × Clear all
NCT00795613 2015-10-19

HD0607

Ospedale Santa Croce-Carle Cuneo

Phase 2 Unknown
450 enrolled
Lymphoid

Hodgkin Disease

NCT00025064 2013-08-07

Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 2 Unknown
260 enrolled
Lymphoid

Lymphoma, Recurrence

NCT01737346 2012-12-03

Procarbazine and Lomustine in Recurrent Glioblastoma

Incheon St.Mary's Hospital

Phase 2 Unknown
52 enrolled
CNS

Glioblastoma, Recurrence

NCT01124240 2011-07-26

ExCentric

Northern Sydney and Central Coast Area Health Service

Phase 2 Unknown
48 enrolled
CNS

Glioblastoma

NCT00989352 2009-10-05

PRIMAIN

University Hospital Freiburg

Phase 2 Unknown
56 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡